Showing results 1 to 20 of 49
next >
| Issue Date | Title | Author(s) |
| 2019 | ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy | Zhong, Jia; Guo, Zihan; Fang, Liping; Zhao, Xinghui; Zhao, Bingqing; Cao, Zhigang; Cheng, Linlin; Shia, Yuanyuan; Li, Xiaoting; Zhang, Yanhua; An, Tongtong; Wu, Meina; Wang, Yuyan; Zhu, Minglei; Li, Jianjie; Yang, Xue; Chen, Hanxiao; Jia, Bo; Zhao, Jun |
| 2013 | Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer | Wang, Shuhang; An, Tongtong; Duan, Jianchun; Zhang, Lijian; Wu, Meina; Zhou, Qinghua; Chen, Jinfeng; Zhuo, Minglei; Yang, Lu; Wang, Yuyan; Bai, Hua; Wang, Jie |
| 2018 | Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer | Lv, Chunxin; Liu, Xiuju; Zheng, Qiwen; Chen, Hanxiao; Yang, Xue; Zhong, Jia; Wang, Yuyan; Duan, Jianchun; Wang, Zhijie; Bai, Hua; Wu, Meina; Zhao, Jun; Wang, Jie; Wang, Ziping; An, Tongtong; Zhuo, Minglei |
| 16-Jul-2020 | Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience | Wang, Lu; Zhao, Jun; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Wu, Meina; Wang, Ziping; Li, Jianjie; Yang, Xue; Chen, Hanxiao; Zhong, Jia |
| 2013 | Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations | An, Tongtong; Wang, Jie; Bai, Hua; Wang, Zhijie; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; Wu, Meina; Wang, Yuyan; Wang, Shuhang |
| 2017 | Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer | Wan, Rui; Wang, Zhijie; Lee, J. Jack; Wang, Shuhang; Li, Qingqing; Tang, Fuchou; Wang, Jin; Sun, Yu; Bai, Hua; Wang, Di; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wu, Meina; Chen, Zhaoli; Yang, Zhenlin; Wang, Jie |
| 2015 | Current small cell lung cancer treatment in China | Shi, Yuankai; Xing, Puyuan; Fan, Yun; Zhang, Xin; Hu, Chengping; Wang, Caixia; Liu, Xiaoqing; Chen, Xiaoxia; Zhou, Jianying; Wang, Mengzhao; Wu, Meina; Han, Baohui; Fan, Min |
| 2013 | Cytoplasmic ER beta expression to predict efficacy and survival of EGFR-TKI in EGFR-mutant NSCLC | Wang, Zhijie; Wang, Jie; Wang, Xiaodong; Shen, Zhirong; Ding, Xiaosheng; Bai, Hua; Duan, Jianchun; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Wang, Shuhang; Wu, Meina |
| 2013 | CYTOPLASMIC ERBEXPRESSION PREDICTS POORLY EFFICACY AND SURVIVAL OF EGFR-TKI IN EGFR MUTANT NSCLC | Wang, Zhijie; Li, Zhenxiang; Bai, Hua; Wang, Jie; Zhao, Jun; Wu, Meina |
| 2013 | Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer | Bai, Hua; Wang, Zhijie; Wang, Yuyan; Zhuo, Minglei; Zhou, Qinghua; Duan, Jianchun; Yang, Lu; Wu, Meina; An, Tongtong; Zhao, Jun; Wang, Jie |
| 2012 | The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI | Huang, Zhen; Wang, Zhijie; Bai, Hua; Wu, Meina; An, Tongtong; Zhao, Jun; Yang, Lu; Duan, Jianchun; Zhuo, Minglei; Wang, Yuyan; Wang, Shuhang; Wang, Jie |
| 2012 | DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer | Zhu, Jian; Wang, Yuyan; Duan, Jianchun; Bai, Hua; Wang, Zhijie; Wei, Lai; Zhao, Jun; Zhuo, Minglei; Wang, Shuhang; Yang, Lu; An, Tongtong; Wu, Meina; Wang, Jie |
| 2013 | DYNAMIC, QUANTITATIVE, AND NON-INVASIVE ANALYSIS OFT790M MUTATION IN MATCHED PLASMA DNA FROM PRE-AND POST-EGFR-TKI TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER | Chen, Rui; Bai, Hua; Wang, Shuhang; Wang, Yuyan; Duan, Jianchun; Wang, Jie; An, Tongtong; Zhuo, Minglei; Wu, Meina |
| 5-May-2021 | Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study | Yang, Xue; Xia, Yang; Xu, Liyan; Liang, Li; Zhuo, Minglei; Wu, Meina; An, Tongtong; Wang, Ziping; Wang, Yuyan; Li, Jianjie; Zhong, Jia; Chen, Hanxiao; Jia, Bo; Wang, Jingjing; Zhao, Jun |
| 2015 | Efficacy and Safety of Weekly Albumin-Bound Paclitaxel for Non-Small-Cell Lung Cancer Patients Who Have Failed >= 2 Prior Systemic Regimens | Wang, Jie; Duan, Jianchun; Hao, Yueqin; Zhao, Jun; Wang, Zhijie; An, Tongtong; Wu, Meina |
| 2010 | EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer | Wu, Meina; Zhao, Jun; Song, Sonya Wei; Zhuo, Minglei; Wang, Xin; Bai, Hua; Wang, Shuhang; Yang, Lu; An, Tongtong; Zhang, Yan; Duan, Jianchun; Wang, Yuyan; Guo, Qingzhi; Liu, Xuyi; Liu, Ninghong; Wang, Jie |
| 2012 | EGFR-TKI benefit for NSCLC patients with EML4-ALK rearrangement | Wang, Zhijie; Wang, Jie; Wu, Yi Long; Bai, Hua; Zhang, Xu-Chao; An, Tongtong; Zhuo, Minglei; Duan, Jianchun; Yang, Lu; Wu, Meina |
| 2012 | EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer | Wang, Zhijie; Zhang, Xuchao; Bai, Hua; Zhao, Jun; Zhuo, Minglei; An, Tongtong; Duan, Jianchun; Yang, Lu; Wu, Meina; Wang, Shuhang; Wang, Yuyan; Wu, Yilong; Wang, Jie |
| 2015 | Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung | Duan, Jianchun; Wang, Zhijie; Bai, Hua; An, Tongtong; Zhuo, Minglei; Wu, Meina; Wang, Yuyan; Yang, Lu; Wang, Jie |
| Mar-2021 | Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I & ndash;IIIA non-small cell lung cancer patients | Jia, Bo; Zheng, Qiwen; Li, Jianjie; Zhao, Jun; Wu, Meina; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Yang, Xue; Chen, Hanxiao; Chi, Yujia; Wang, Jingjing; Zhai, Xiaoyu; He, Yuling; Kong, Lingdong; Wang, Ziping |
